Efficacy and Safety of Vandetanib in Progressive and Symptomatic Medullary Thyroid Cancer: Post Hoc Analysis From the ZETA Trial - Concepedia

Concepedia

Publication | Open Access

Efficacy and Safety of Vandetanib in Progressive and Symptomatic Medullary Thyroid Cancer: Post Hoc Analysis From the ZETA Trial

DOI Full Paper Access

57

Citations

12

References

2020

Year

Michael C. Kreißl, Lars Bastholt, Rossella Elisei, Robert I. Haddad, Ole Hauch, Barbara Jarząb, Bruce Robinson, Raffaella Colzani, Meredith C. Foster, R. J. Weiss,

Journal of Clinical Oncology

Abstract

Vandetanib demonstrated clinical benefit-specifically, increased PFS-in patients with symptomatic and progressive MTC.

References

	Year	Citations

Page 1